Further limitations of the in vivo studies are the inconsistency of verifying the SOD expression in the plasmid therapy [62,63] and limited evidence correlating signs of OM improvement with ROS [17,26,34,36,56], a more direct method of measuring oxidative stress. Here, SOD1 is linked to ocular melanoma.